Nifty

:

23270.60

Sensex

:

74314.59

53.00 (0.23%)
-21.86 (-0.03%)

Login

Nifty
Sensex

:
:

23270.60
74314.59

53.00 (0.23%)
-21.86 (-0.03%)

Alivus Life Sciences Ltd.

Pharmaceuticals & Drugs

Rating :

74/99

BSE: 543322 | NSE: ALIVUS

Watchlist

NSE BSE

1387.80

17-Sep-2026

Open
High
Low
Previous Close

1372.8
1397.9
1361.1
1370.60

Volume
Traded Value (lacs)
52 Week High
52 Week Low

72107
99856838.7
1493.8
819

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

17,029.01
27.92
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

17,026.88
0.36%
4.83

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
3.75
3.78

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
5.29
3.41

PAT CAGR (%)

10 Years
5 Years
3 Years

-
6.16
6.23

P:E (Median)

8 Years
5 Years
3 Years

-
20.96
23.24

P:BV (Average)

8 Years
5 Years
3 Years

-
3.73
4.29

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
13.25
15.83

Earnings Forecasts:

(Updated: 12-09-2026)

Description 2026 2027 2028 2029
Adj EPS 56 10 12.8 46.34
P/E Ratio 24.78 138.78 108.42 29.95
Revenue 22.48 19.66 18.24 2571.86
EBITDA 2814.7 3126.18 3433.1 794.16
Net Income 876.88 997.55 1086.7 565.62
ROA 626.85 711.63 780.2 -
P/B Ratio -15.93 -3.32 - 5.38
ROE 3.66 3.15 - 19.51
FCFF 18.1 17.98 16.2 253.79
FCFF Yield 159.4 386.85 - 1.88
Net Debt 1.18 2.87 - -75.2
BVPS -87.1 -418.5 - 258.08

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 640.41 601.85 6.41% 689.12 649.54 6.09% 672.89 641.84 4.84% 587.98 506.88 16.00%
Expenses 428.70 429.54 -0.20% 474.59 451.11 5.20% 441.62 451.54 -2.20% 408.81 372.52 9.74%
EBITDA 211.71 172.31 22.87% 214.53 198.43 8.11% 231.27 190.31 21.52% 179.17 134.36 33.35%
EBIDTM 33.06% 28.63% 31.13% 30.55% 34.37% 29.65% 30.47% 26.51%
Other Income 22.40 8.98 149.44% 22.78 10.09 125.77% 13.93 10.46 33.17% 14.72 8.53 72.57%
Interest 1.31 1.25 4.80% 1.31 1.26 3.97% 1.49 0.46 223.91% 1.32 0.34 288.24%
Depreciation 20.59 17.06 20.69% 20.20 15.97 26.49% 19.66 15.16 29.68% 18.43 15.09 22.13%
PBT 212.22 162.98 30.21% 215.80 191.29 12.81% 198.39 185.15 7.15% 174.14 127.46 36.62%
Tax 52.15 41.45 25.81% 53.14 49.42 7.53% 48.13 48.19 -0.12% 44.11 32.14 37.24%
PAT 160.08 121.53 31.72% 162.66 141.87 14.65% 150.26 136.96 9.71% 130.03 95.32 36.41%
PATM 25.00% 20.19% 23.60% 21.84% 22.33% 21.34% 22.11% 18.80%
EPS 13.05 9.91 31.69% 13.26 11.56 14.71% 12.25 11.16 9.77% 10.60 7.77 36.42%

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Net Sales 2,590.40 2,551.83 2,386.88 2,283.21 2,161.22 2,123.21 1,885.16 1,537.31 886.42 0.25 Net Sales Growth 7.93% 6.91% 4.54% 5.64% 1.79% 12.63% 22.63% 73.43% 354468.00% Cost Of Goods Sold 1,051.23 1,027.83 1,037.44 968.64 984.12 1,019.28 877.46 664.02 331.97 0.09 Gross Profit 1,539.17 1,524.00 1,349.44 1,314.58 1,177.10 1,103.93 1,007.70 873.29 554.45 0.16 GP Margin 59.42% 59.72% 56.54% 57.58% 54.46% 51.99% 53.45% 56.81% 62.55% 64.00% Total Expenditure 1,753.72 1,754.55 1,704.30 1,608.97 1,518.93 1,507.15 1,294.09 1,065.35 639.25 0.26 Power & Fuel Cost - 113.88 117.24 112.46 115.60 100.92 74.19 76.75 57.81 0.00 % Of Sales - 4.46% 4.91% 4.93% 5.35% 4.75% 3.94% 4.99% 6.52% 0% Employee Cost - 272.47 251.70 258.16 180.18 168.72 149.13 142.28 106.28 0.15 % Of Sales - 10.68% 10.55% 11.31% 8.34% 7.95% 7.91% 9.26% 11.99% 60.0% Manufacturing Exp. - 212.31 177.41 163.63 137.17 124.04 107.61 108.03 77.23 0.00 % Of Sales - 8.32% 7.43% 7.17% 6.35% 5.84% 5.71% 7.03% 8.71% 0% General & Admin Exp. - 58.17 52.56 55.14 46.45 54.18 43.36 44.09 29.51 0.02 % Of Sales - 2.28% 2.20% 2.42% 2.15% 2.55% 2.30% 2.87% 3.33% 8.00% Selling & Distn. Exp. - 56.38 53.92 38.52 45.10 31.78 33.79 26.32 27.91 0.00 % Of Sales - 2.21% 2.26% 1.69% 2.09% 1.50% 1.79% 1.71% 3.15% 0% Miscellaneous Exp. - 13.51 14.03 12.41 10.30 8.23 8.54 3.86 8.53 0.00 % Of Sales - 0.53% 0.59% 0.54% 0.48% 0.39% 0.45% 0.25% 0.96% 0% EBITDA 836.68 797.28 682.58 674.24 642.29 616.06 591.07 471.96 247.17 -0.01 EBITDA Margin 32.30% 31.24% 28.60% 29.53% 29.72% 29.02% 31.35% 30.70% 27.88% -4.00% Other Income 73.83 60.41 34.57 12.04 28.96 14.70 0.81 11.99 0.99 0.00 Interest 5.43 5.37 2.41 1.55 0.55 27.96 87.55 33.52 0.61 0.00 Depreciation 78.88 75.36 60.61 53.45 42.09 37.88 33.39 29.37 19.26 0.00 PBT 800.55 776.97 654.13 631.29 628.61 564.92 470.94 421.07 228.30 -0.01 Tax 197.53 186.83 168.50 160.40 161.65 146.20 119.36 107.97 32.70 0.42 Tax Rate 24.67% 24.87% 25.76% 25.41% 25.72% 25.88% 25.35% 25.64% 14.32% -4200.00% PAT 603.03 564.48 485.63 470.89 466.96 418.72 351.58 313.10 195.59 -0.43 PAT before Minority Interest 603.03 564.48 485.63 470.89 466.96 418.72 351.58 313.10 195.59 -0.43 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 23.28% 22.12% 20.35% 20.62% 21.61% 19.72% 18.65% 20.37% 22.07% -172.00% PAT Growth 21.66% 16.24% 3.13% 0.84% 11.52% 19.10% 12.29% 60.08% - EPS 49.15 46.00 39.58 38.38 38.06 34.13 28.65 25.52 15.94 -0.04

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Shareholder's Funds 3,332.13 2,817.37 2,332.32 2,138.21 2,054.31 752.75 401.69 88.13 -1.40 Share Capital 24.55 24.51 24.50 24.50 24.50 1.96 1.96 1.96 0.01 Total Reserves 3,300.34 2,782.90 2,296.76 2,107.02 2,026.31 750.79 399.73 86.17 -1.41 Non-Current Liabilities 142.73 466.05 756.95 67.40 32.70 22.89 16.45 6.86 0.00 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 36.15 360.67 693.40 7.87 0.00 0.00 0.00 0.00 0.00 Current Liabilities 682.24 470.16 438.77 1,014.89 746.80 1,444.93 1,307.46 1,380.41 1.48 Trade Payables 372.37 390.46 368.66 427.23 307.72 221.31 201.07 182.89 0.01 Other Current Liabilities 99.30 62.74 58.08 54.57 49.84 966.54 1,084.03 1,181.11 1.46 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.02 0.00 Short Term Provisions 210.57 16.96 12.03 533.09 389.24 257.08 22.34 16.40 0.01 Total Liabilities 4,157.10 3,753.58 3,528.04 3,220.50 2,833.81 2,220.57 1,725.60 1,475.40 0.08 Net Block 1,037.55 954.95 805.06 780.63 589.76 572.80 546.25 456.31 0.00 Gross Block 1,366.62 1,218.71 1,012.33 936.48 705.53 651.90 594.82 475.57 0.00 Accumulated Depreciation 329.07 263.76 207.26 155.85 115.77 79.10 48.58 19.26 0.00 Non Current Assets 1,333.54 1,418.43 1,612.05 851.81 706.42 598.03 565.49 544.70 0.00 Capital Work in Progress 283.75 101.91 105.99 61.62 96.95 14.10 10.73 80.39 0.00 Non Current Investment 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.00 Long Term Loans & Adv. 12.16 361.49 700.92 9.49 19.63 11.06 8.44 7.92 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 2,823.56 2,335.16 1,916.00 2,368.68 2,127.39 1,622.53 1,160.11 930.70 0.08 Current Investments 780.38 477.62 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 691.93 673.95 666.59 604.17 516.24 513.42 412.77 400.84 0.04 Sundry Debtors 1,072.96 969.74 765.43 806.77 673.49 619.50 638.63 448.09 0.03 Cash & Bank 2.13 71.24 301.59 309.40 512.16 115.60 10.00 2.06 0.01 Other Current Assets 276.16 42.25 91.69 71.72 425.50 374.02 98.72 79.71 0.01 Short Term Loans & Adv. 237.46 100.37 90.69 576.63 419.54 348.29 77.61 73.92 0.01 Net Current Assets 2,141.32 1,865.00 1,477.23 1,353.80 1,380.59 177.60 -147.35 -449.72 -1.40 Total Assets 4,157.10 3,753.59 3,528.05 3,220.49 2,833.81 2,220.56 1,725.60 1,475.40 0.08

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Cash From Operating Activity 565.41 391.52 413.51 306.01 597.59 388.11 195.01 10.35 -0.48 PBT 751.31 654.13 631.29 628.61 564.92 470.94 421.07 228.30 -0.01 Adjustment 115.90 80.72 79.27 44.62 70.99 133.31 56.74 -101.15 0.00 Changes in Working Capital -128.54 -180.38 -134.08 -213.66 99.84 -107.58 -190.26 -93.26 -0.47 Cash after chg. in Working capital 738.67 554.48 576.48 459.57 735.75 496.68 287.54 33.89 -0.48 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -173.26 -162.95 -162.96 -153.56 -138.17 -108.56 -92.54 -23.54 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -570.15 -615.64 -116.48 -146.75 -122.23 -68.73 -50.52 -8.91 0.00 Net Fixed Assets -329.75 -202.30 -120.22 -195.62 -136.48 -60.45 -49.59 -555.96 Net Investments -302.76 -477.62 0.00 0.00 0.00 0.00 0.00 -0.08 Others 62.36 64.28 3.74 48.87 14.25 -8.28 -0.93 547.13 Cash from Financing Activity -64.34 -6.23 -279.44 -387.59 -78.80 -213.78 -136.55 0.54 0.49 Net Cash Inflow / Outflow -69.08 -230.35 17.59 -228.33 396.56 105.60 7.94 1.97 0.01 Opening Cash & Equivalents 71.06 301.41 283.82 512.16 115.60 10.00 2.06 0.01 0.00 Closing Cash & Equivalent 1.98 71.06 301.41 283.82 512.16 115.60 10.00 2.06 0.01

Financial Ratios

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Book Value (Rs.) 270.90 229.11 189.45 173.97 167.38 69.83 37.26 449.62 -1398.00 ROA 14.27% 13.34% 13.96% 15.43% 16.57% 17.82% 19.56% 26.51% -510.59% ROE 18.41% 18.94% 21.15% 22.33% 29.87% 60.91% 127.84% 451.05% 0.00% ROCE 24.61% 25.50% 28.31% 30.01% 42.24% 96.75% 185.60% 527.74% 0.00% Fixed Asset Turnover 1.99 2.15 2.35 2.65 3.13 3.03 2.88 3.73 248.00 Receivable days 144.58 132.12 125.30 124.34 111.01 121.50 128.84 92.26 45.63 Inventory Days 96.67 102.08 101.28 94.11 88.40 89.45 96.46 82.54 55.93 Payable days 135.45 133.54 149.95 136.29 94.72 87.85 65.75 52.18 24.84 Cash Conversion Cycle 105.80 100.66 76.63 82.16 104.69 123.10 159.54 122.62 76.71 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 140.86 271.97 409.34 1150.19 21.20 6.38 13.56 378.35 0.00

Top Investors:

quant mutual fund - quant small cap fund

government pension fund global

massachusetts institute of technology

Annual Reports:

News Update:

Alivus Life Sciences gets nod to acquire 76% stake in IQGEN-X Pharma
19th Aug 2026, 14:09 PM

The Board of Directors of the company at its meeting held on August 18, 2026, approved the same
Read More
Alivus Life Sciences - Quarterly Results
31st Jul 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback